John Maraganore bought $249K of RAPP stock

John Maraganore, Dir of Rapport Therapeutics, Inc. (RAPP), bought 9,411 shares of RAPP stock worth $249K, per an SEC Form 4 filed Oct 22, 2026.

It was an open-market purchase.

The trade was reported on Oct 22, 2026.

RAPP has moved -2.6% since the trade date, from $26.53 to $25.85 (Nov 12, 2026 close).